PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹367 Cr | ₹309 Cr | ₹330 Cr | ₹774 Cr | ₹447 Cr |
What is the latest Total Current Liabilities ratio of PANACEA BIOTEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹309 Cr |
| Mar2023 | ₹330 Cr |
| Mar2022 | ₹774 Cr |
| Mar2021 | ₹447 Cr |
How is Total Current Liabilities of PANACEA BIOTEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 18.77 | |
| Mar2024 | ₹309 Cr | -6.29 | |
| Mar2023 | ₹330 Cr | -57.39 | |
| Mar2022 | ₹774 Cr | 73.01 | |
| Mar2021 | ₹447 Cr | - | |
Compare Total Current Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,420.4 Cr | -2.9% | -4.7% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -2.9% |
-4.7% |
-3.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses